Insider trades
Almstead Neil Gregory
Almstead Neil Gregory made 0 buys and 23 sales on the open market in the last 12 months at PTC Therapeutics, Inc. Each trade with the role, price and filing.
Insider trades
Where they report
| Company | Role | Holding after | Latest trade |
|---|---|---|---|
| PTC Therapeutics, Inc. NASDAQ:PTCT | CHIEF TECHNICAL OPS OFFICER | 60,299 | Jul 9, 2026 |
Open-market trades, newest first
| Company | Date | Trade | Shares | Price | Value | Holding after | Filed |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 9, 2026 | Sale | 2,464 | US$90.25 | US$222K | 60,299 | Jul 13, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 7, 2026 | Sale | 9,288 | US$89.44 | US$831K | 60,299 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 7, 2026 | Sale | 11,369 | US$89.03 | US$1.01M | 69,587 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 7, 2026 | Sale | 3,956 | US$87.17 | US$345K | 80,956 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 6, 2026 | Sale | 385 | US$86.34 | US$33,241 | 60,299 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 6, 2026 | Sale | 426 | US$85.28 | US$36,329 | 60,684 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 6, 2026 | Sale | 2,474 | US$87.03 | US$215K | 60,299 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 6, 2026 | Sale | 8,786 | US$85.35 | US$750K | 70,389 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jul 6, 2026 | Sale | 10,090 | US$86.32 | US$871K | 60,299 | Jul 8, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 26, 2026 | Sale | 412 | US$85.23 | US$35,115 | 60,137 | Jun 30, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 26, 2026 | Sale | 7,718 | US$85.26 | US$658K | 60,137 | Jun 30, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 25, 2026 | Sale | 419 | US$86.39 | US$36,197 | 60,137 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 25, 2026 | Sale | 8,522 | US$85.26 | US$727K | 71,474 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 25, 2026 | Sale | 11,337 | US$86.51 | US$981K | 60,137 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 25, 2026 | Sale | 100 | US$87.00 | US$8,700 | 60,137 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 25, 2026 | Sale | 582 | US$85.24 | US$49,610 | 60,556 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 24, 2026 | Sale | 401 | US$85.01 | US$34,089 | 60,137 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 24, 2026 | Sale | 4,922 | US$85.03 | US$419K | 60,137 | Jun 26, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 22, 2026 | Sale | 11,619 | US$81.21 | US$944K | 60,137 | Jun 24, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Jun 22, 2026 | Sale | 12,130 | US$80.61 | US$978K | 71,756 | Jun 24, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Apr 1, 2026 | Sale | 39,393 | US$68.89 | US$2.71M | 72,747 | Apr 3, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Apr 1, 2026 | Sale | 80 | US$70.30 | US$5,624 | 60,137 | Apr 3, 2026 |
| PTC Therapeutics, Inc. NASDAQ:PTCT | Apr 1, 2026 | Sale | 12,530 | US$69.50 | US$871K | 60,217 | Apr 3, 2026 |